Author Archives: Kristine Meredith

Yaz Trial Delayed

The first Yasmin/Yaz trial involving a woman who suffered a pulmonary embolism after taking the birth control pill scheduled to begin next week has been delayed by Judge Herndon, the federal judge presiding over thousands of lawsuits. In an order … Continue reading

Posted in Yaz Lawsuits | Tagged | Comments Off

Current Yasmin and Yaz Label Warnings Are Inadequate

Seated around a U-shaped configuration of tables sat the 26 member FDA Advisory Committee — all scientists or physicians gathered to discuss the risks of birth control pills containing DRSP. They focused on the risks as described in recent studies, … Continue reading

Posted in Yaz & the FDA | Tagged , , | Comments Off

New Dutch Study Shows Yaz has Greater VTE Risk

A Dutch research team has published a new study concluding that Yaz has a greater risk of causing blood clots than other birth control pills. The Dutch cohort study looked at over one million women from 2001-2008. Researchers confirmed nearly … Continue reading

Posted in Yaz Science & Chemistry | Tagged , | Comments Off

More Evidence that Yaz carries an increased risk of VTE

  The FDA posted the results of its much anticipated large retrospective study about the risk of venous thrombotic events (VTEs) and  newer contraceptives containing drosperinone (DRSP)  such as Yasmin, Yaz and Beyaz. The FDA reports “In adjusted analyses, DRSP … Continue reading

Posted in Yaz & the FDA | Tagged , | Comments Off

FDA Safety Committees will examine the risks of Yasmin/Yaz/Beyaz as compared to levonorgestrel birth control pills.

Two FDA Safety Committees will hold public meetings about the risks of Yaz on December 8, 2011. The two committees to meet are (1) the 13-member Reproductive Health Drugs Advisory Committee and (2) the 13-member Drug Safety and Risk Management … Continue reading

Posted in Yaz & the FDA, Yaz Science & Chemistry | Tagged , | Comments Off

FDA Remains Inconclusive Regarding Drospirenone Study Results

The FDA has communicated a luke warm statement about the safety of birth control pills containing drospirenone, stating that it “has not yet reached a conclusion and remains concerned.” Consumers continue to await the final results of the FDA-funded study … Continue reading

Posted in Yaz & the FDA | Tagged , | Comments Off

Tennessee College Student Suffers Pulmonary Embolism after taking Yaz

I just read a story that aired in Tennessee on NewsChannel 5 about a woman named Leah. Leah was a twenty year old student at Tennessee Tech and on her way to becoming a nurse when, last January, her college … Continue reading

Posted in Women's Stories, Yaz Side Effects | Tagged , | Comments Off

Yaz Lawsuits Mount

The  San Francisco Daily Journal ran a front-page story on the Yaz cases recently, and by doing so helped to get the word out about the dangers of Yaz and Yasmin. Susan Galinis discussed her stroke and the effect it … Continue reading

Posted in Women's Stories, Yaz Lawsuits | Tagged , | Comments Off

Podcast Examines FDA Role in Monitoring Yaz Dangers

Lawyer2Lawyer is a legal talk show that brings together lawyers with opposing views from across the country.  On its show devoted to the growing number of Yaz lawuits, Lawyer2Lawyer interviewed Mike Danko and Professor James O’Reilly, from the University of Cincinnati College … Continue reading

Posted in Yaz & the FDA, Yaz Lawsuits | Comments Off